SmithRx company logo
SmithRx
Actively Hiring
Smart Pharmacy Benefits Made Simple 501-1000 Employees
  • B2B
  • Growth Stage
    Expanding market presence
  • Top Investors
    This company has received a significant amount of investment from top investors

SmithRx careers

Smart Pharmacy Benefits Made Simple
SmithRx is a next-generation pharmacy benefit partner built on a modern technology platform that creates new levels of flexibility, efficiency, and customer satisfaction. It’s a new path forward that aligns incentives and harnesses data analytics to deliver an exceptional pharmacy benefit product.

A San Francisco based technology company, SmithRx was founded in 2016 to create a cost-competitive PBM that offers clients a proven pass-through model, a single platform technology, concierge level service, and strong drug cost, rebate, and service level guarantees. The 100% in-house team brings together experience from healthcare companies including Anthem and Safeway Pharmacy along with Silicon Valley technology leaders. Front-line clinicians guide plan execution and member support.

Find out more at smithrx.com

Staff Data Analyst

Remote only • United States
$120k – $170k
5 days ago

Strategic Finance Manager

Remote only • Alaska, United States • Hawaii, United States • New York City, New York
$106k – $150k
1 month ago

GTM Finance Senior Manager / Director

Remote only • Illinois, United States • Kentucky, United States • New York City, New York
$161k – $264k
1 month ago

Senior Salesforce Administrator

Remote only • San Francisco Bay Area, United States • Idaho, United States • Indiana, United States
$127k – $180k
1 month ago

Business Systems Analyst

Remote only • Michigan, United States • Montana, United States • New Hampshire, United States
$93k – $151k
1 month ago
2 months ago

Senior Software Engineer, Platform

Remote only • United States

Sales Manager

San Francisco • Lehi
Alexandra Morrison
Avatar for Alexandra Morrison
Alex Flatbush
Avatar for Alex Flatbush
Charles Harris
Avatar for Charles Harris
In-house counsel to SmithRx and former associate with Hunton & Williams LLP
Valuation

$0

Funded over

3 rounds

Latest round

Series A (Jul 2018)